Dr. H. Zoghbi invested as member of the American Academy of Sciences and Letters. @bcmhouston@bcmgenetics @TCHResearchNews @TexasChildrens https://t.co/NFQ8WAAty4
🌸 In honor of #BreastCancerAwarenessMonth, Heather Machado, PhD, discusses her research on breast cancer & mammary gland development at Tulane School of Medicine.
Learn more about her work and passion for mentoring in this episode of #TulaneMedInsider! #BreastCancerResearch
Surprising consistency between paired Mets and Primary supports the seed and soil hypothesis. T cells recruited systemically but metastatic macrophages look local. Rich data!
@BCRFcure begins the event by acknowledging @judygarber5 opening remarks. The BCRF is the most generous foundations for breast cancer research, supporting investigators in making breakthroughs.
Happy to share our latest work showing that an ancient ER-localized RNase IRE1 coordinates with p53 to silence taxane-induced dsRNA and protect immune-cold TNBC from pore-forming pyroptosis. @CellCellPress @MDAndersonNews https://t.co/GcJegUOXXs
Also check out the first place winner of our scientific image contest! The picture “Mitochondrial mischief” was taken by Dr. Lily Baek. The image illustrates the chaotic cellular response of a triple-negative breast cancer cell to stress induced by chemotherapy. #DLDCCC
This afternoon kicks off the 19th Dan L Duncan Comprehensive Cancer Center Symposium with our poster session! Come see the posters at Main Baylor until 5 p.m. today. #DLDCCC
.@UHCancerCenter successfully hosted our inaugural breast cancer community event, ‘Ohana Pink. Fantastic turnout, with attendees coming together to support and raise awareness about breast cancer. A privilege to have the event led by Dr. Jami Fukui, whose dedication and leadership made this gathering a meaningful experience for all involved.
Researchers discover new insights into tumor-induced B cell changes in blood and bone marrow of triple negative breast cancer patient that could serve as biomarkers for treatment response. https://t.co/PDlhwkJHfK #TripleNegativeBreastCancer#BreastCancerResearch
3/4 Tumor-induced B cell abnormalities in breast cancer are associated with abnormal myelopoiesis and systemic immunosuppression, which correlate with immunotherapy responses and highlight the need for personalized treatment.
@XiangZhangLab@bcmhouston
https://t.co/tf7oW6jmB7
You can help by considering donating your healthy breast tissue to the Komen Tissue Bank at our upcoming collection event October 19, 2024. You can register to donate here https://t.co/sd0Fdzy0X3. Also, we want to hear from you. Ask us your questions here [email protected].
Drs. Karla Sepulveda and Alastair Thompson stress the importance of early detection for breast cancer. https://t.co/tUelWM4OKY #breastcancer#breastcancerawarenessmonth
Our study characterizing breast cancer brain metastasis is officially out in @PNASNews. We reproted breast cancer-stromal cells interaction induces resistance to HER2-targeting agents via bulky glycoproteins. Congrats to @MarieAnneGoyet1 and @nellage.
https://t.co/adB0G5dm80